Your browser doesn't support javascript.
loading
Aminobisphosphonates reactivate the latent reservoir in people living with HIV-1.
Sanz, Marta; Weideman, Ann Marie K; Ward, Adam R; Clohosey, Matthew L; Garcia-Recio, Susana; Selitsky, Sara R; Mann, Brendan T; Iannone, Marie Anne; Whitworth, Chloe P; Chitrakar, Alisha; Garrido, Carolina; Kirchherr, Jennifer; Coffey, Alisha R; Tsai, Yi-Hsuan; Samir, Shahryar; Xu, Yinyan; Copertino, Dennis; Bosque, Alberto; Jones, Brad R; Parker, Joel S; Hudgens, Michael G; Goonetilleke, Nilu; Soriano-Sarabia, Natalia.
Afiliação
  • Sanz M; Department of Microbiology Immunology and Tropical Medicine, the George Washington University, Washington DC, USA.
  • Weideman AMK; Department of Biostatistics, University of North Carolina at Chapel Hill, North Carolina, USA.
  • Ward AR; Department of Microbiology Immunology and Tropical Medicine, the George Washington University, Washington DC, USA.
  • Clohosey ML; Department of Infectious Diseases, Weill Cornell Medicine, New York, USA.
  • Garcia-Recio S; UNC HIV-1 Cure Center, University of North Carolina at Chapel Hill, North Carolina, USA.
  • Selitsky SR; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, North Carolina, USA.
  • Mann BT; Department of Genetics, University of North Carolina at Chapel Hill, North Carolina, USA.
  • Iannone MA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, North Carolina, USA.
  • Whitworth CP; Department of Genetics, University of North Carolina at Chapel Hill, North Carolina, USA.
  • Chitrakar A; Department of Microbiology Immunology and Tropical Medicine, the George Washington University, Washington DC, USA.
  • Garrido C; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, North Carolina, USA.
  • Kirchherr J; UNC HIV-1 Cure Center, University of North Carolina at Chapel Hill, North Carolina, USA.
  • Coffey AR; Department of Microbiology Immunology and Tropical Medicine, the George Washington University, Washington DC, USA.
  • Tsai YH; UNC HIV-1 Cure Center, University of North Carolina at Chapel Hill, North Carolina, USA.
  • Samir S; UNC HIV-1 Cure Center, University of North Carolina at Chapel Hill, North Carolina, USA.
  • Xu Y; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, North Carolina, USA.
  • Copertino D; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, North Carolina, USA.
  • Bosque A; Microbiology & Immunology, University of North Carolina at Chapel Hill, North Carolina, USA.
  • Jones BR; Microbiology & Immunology, University of North Carolina at Chapel Hill, North Carolina, USA.
  • Parker JS; Department of Infectious Diseases, Weill Cornell Medicine, New York, USA.
  • Hudgens MG; Department of Microbiology Immunology and Tropical Medicine, the George Washington University, Washington DC, USA.
  • Goonetilleke N; Department of Microbiology Immunology and Tropical Medicine, the George Washington University, Washington DC, USA.
  • Soriano-Sarabia N; Department of Infectious Diseases, Weill Cornell Medicine, New York, USA.
bioRxiv ; 2023 Feb 07.
Article em En | MEDLINE | ID: mdl-36798291
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: BioRxiv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: BioRxiv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos